Press release
Rheumatology Therapeutics Market Poised for 4.8 % Growth, Set to Hit $4.26 Billion by 2029
Rheumatology Therapeutics Market
The size of the rheumatology therapeutics market has amplified significantly in the past few years. It is projected to escalate from $42.4 billion in 2024 to $44.61 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. The expansion during the historic period is credited to the increasing occurrence of rheumatologic disorders, growth in the global elderly population, heightened awareness of available treatments, advancements in biologic therapies, and improved healthcare accessibility in developing markets.
In the coming years, the rheumatology therapeutics market is projected to experience steady growth, expanding to $53.88 billion in 2029 with a compound annual growth rate (CAGR) of 4.8%. This projected growth during the forecast period is linked to the shift towards personalized medicine, increased uptake of biosimilars in rheumatology, rising investment in R&D, the integration of digital health technologies, and the approval of new therapies by regulatory bodies. Key trends in the forecast period encompass the growth of telemedicine and remote monitoring solutions, the development of targeted therapies for specific rheumatic conditions, a focus on patient-centric care models, the broadening of biologic treatments beyond monoclonal antibodies, and the adoption of value-based pricing models.
What Is Driving the Growth Trajectory of the Rheumatology Therapeutics Market?
Expectations are high for the rheumatology therapeutics market to expand due to the increasing occurrence of autoimmune disorders. Autoimmune diseases, where the immune system mistakenly targets and harms the body's own tissues, are on the rise due to a mix of genetic, environmental, and lifestyle factors. These conditions are also better understood and diagnosed thanks to heightened awareness and improved detection methods. To manage the inflammation caused by these diseases, alleviate associated symptoms, and prevent joint and tissue damage resulting from body attacks by the immune system, rheumatology therapeutics are essential. The Australian Institute of Health and Welfare, a government agency in Australia, in June 2024 reported that approximately 514,000 Australians, or 2.0% of the population, were living with rheumatoid arthritis in 2022. Rheumatoid arthritis represented 2.0% of the overall disease load and 16% of the burden of all musculoskeletal conditions in 2023. Consequently, the surge in autoimmune disorders is fueling the growth of the rheumatology therapeutics market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp
Who Are the Major Industry Players Fueling Rheumatology Therapeutics Market Expansion?
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.
Which Key Developments Are Influencing the Rheumatology Therapeutics Market?
Leading corporations in the field of rheumatology therapeutics are working on ground-breaking solutions such as intravenous (IV) formulations to uplift the efficacy of the treatment and make them more convenient for the patients. An intravenous (IV) formulation is a method where medication or a substance is directly administered into a vein through the use of a needle or catheter. As an example, Novartis AG, a pharmaceutical organization based in Switzerland reported in October 2023 that Cosentyx, an intravenous (IV) formulation, received approval from the US Food and Drug Administration (FDA). This particular formulation of Cosentyx is exclusively granted approval to treat adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). The formulation operates by specifically targeting and inhibiting interleukin-17A (IL-17A) and is the single non-tumor necrosis factor alpha (TNF-a) IV treatment available for these disorders.
How Is the Segmentation of the Rheumatology Therapeutics Market Defined?
The rheumatology therapeutics market covered in this report is segmented -
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications
Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
What Is the Leading Region in the Rheumatology Therapeutics Market?
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Rheumatology Therapeutics Global Market Report?
- Market Size Analysis: Analyze the Rheumatology Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Rheumatology Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Rheumatology Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Rheumatology Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatology Therapeutics Market Poised for 4.8 % Growth, Set to Hit $4.26 Billion by 2029 here
News-ID: 3868870 • Views: …
More Releases from The Business Research Company
Top Factor Driving Surfing Boards Market Growth in 2025: Growing Awareness Fuels …
Which drivers are expected to have the greatest impact on the over the surfing boards market's growth?
The rising interest in outdoor sports activities is expected to stimulate the growth of the surfing board market. Outdoor sports, known for their health benefits, are gaining popularity, and surfing has emerged as a key activity. Innovations in surfing boards are enhancing safety and performance, attracting more enthusiasts. For example, a report by the…
Comprehensive Subcutaneous Immunoglobulin (SCIG) Market Insights: Forecasting Si …
What industry-specific factors are fueling the growth of the subcutaneous immunoglobulin (scig) market?
The rise in secondary immunodeficiency diseases is expected to drive the growth of the subcutaneous immunoglobulin market. Secondary immunodeficiency diseases, caused by factors such as aging populations and immunosuppressive treatments, reduce immune function. Subcutaneous immunoglobulin therapy helps strengthen the immune system by providing necessary antibodies. The UK Health Security Agency reported in October 2023 that new HIV diagnoses…
Leading Element Driving Change in the Sterile Tube Welder Market in 2025: Preval …
What combination of drivers is leading to accelerated growth in the sterile tube welder market?
The rising incidence of blood disorders is expected to drive the growth of the sterile tube welder market. Blood disorders, including conditions that affect blood components, are becoming more common due to genetic, medical, and environmental factors. Sterile tube welders are essential for connecting tubes in blood processing and transfusion procedures while ensuring no contamination. For…
Leading Growth Driver in the Starter Credit Cards Market in 2025: Impact Of Digi …
How Are the key drivers contributing to the expansion of the starter credit cards market?
The increasing adoption of digital payments is expected to fuel the growth of the starter credit card market. Digital payments, conducted electronically via mobile or online platforms, are gaining popularity due to their convenience, enhanced security, and the rise of smartphones. Starter credit cards enable those with limited credit histories to participate in digital transactions, supporting…
More Releases for Rheumatology
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty
December 05-06, 2022 | Dubai, UAE
Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty
Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.
Audience Profile:
· …
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology…
Increasing burden of rheumatology diseases globally is propelling the growth of …
Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to…
Rheumatology Therapeutics Market-Technological Breakthroughs by 2025
heumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to…
Rheumatology Therapeutics Market: Burgeoning Elderly Population Drives Growth
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. Some other key players in the market are Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025…
Global Rheumatology Market to 2024
Global rheumatology market was valued at $31bn in 2015 and is forecast to grow at a modest 4.0% CAGR between 2015 and 2024 to reach 2024 global sales of $46bn.
http://optimainsights.org/request-toc/global-rheumatology-market-to-2024
Rheumatology encompasses numerous musculoskeletal and autoimmune diseases that cause systemic manifestations including joint pain, inflammation and destruction. Worldwide, over 470 million people suffer from rheumatologic diseases. Rheumatology represents a significant disease burden with annual costs associated with rheumatologic diseases estimated at…
